All G is an Australian biotechnology company producing high-value bovine and human milk proteins through precision fermentation. We make scarce, costly, or impossible-to-source proteins accessible and scalable for supplement, functional food, and early-life nutrition brands.
Our first commercial product is LFX™, a next-generation bovine apo-lactoferrin with enhanced iron-binding capacity. Lactoferrin is one of the most sought-after and supply-constrained ingredients in nutrition, valued for its role in immunity, gut health, and iron regulation. LFX™ delivers lactoferrin at a bio activity, purity, and volume that conventional milk extraction cannot match. It is GRAS and has received a “no questions” letter from the FDA for use in adult nutrition.
LFX™ is the first step in a larger vision: a next-generation portfolio of human milk proteins, including human lactoferrin (launching later in 2026), human micellar caseins, and other bio active proteins. Through this platform, All G aims to bring human and infant nutrition closer to human milk and unlock large-scale supply of high-value bio active proteins that have long been out of reach.
Get in touch with All G and ask about our portfolio of next generation proteins for your next formulation.